Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery
Ben Dowsing, British Heart Foundation Clinical Research Fellow at UCL, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Heart Journal, adding:
“Delighted to have presented HER-SAFE as a late breaking clinical trial at ESC 2026.
A first in population randomised controlled trial of heart failure therapy withdrawal in breast cancer survivors with recovered anti-HER2 cardiotoxicity.
HFT withdrawal appears feasible in most, with stable CMR derived cardiac function over 12 months.
Importantly this is first prospective, randomised evidence to guide shared decision making in this growing but often overlooked population.
HFT withdrawal may be an option for most, provided close surveillance is in place and the low risk of reversible, asymptomatic relapse is apparent.
A huge thank you to the participants, BHF and study team without whom this first of its kind work would not have been feasible.
Read the full manuscript in the European Heart Journal.”
Title: Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial
Authors: B Dowsing, H-M Dehbi, M S Andres, R Chung, A Oashou, J M Wilson, I Hussein, B Meredith, I Pierce, S Ahmed, J Pedra, O Worn, M Howe, S Assadullah, P Schmid, R Roylance, T Crake, M Westwood, A K Ghosh, D Auger, C M Plymen, J Baksi, M S Nazir, J C Moon, D Chen, A R Lyon, J M Walker, C H Manisty

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:06Khalid Alfawaz: Signed Consent Doesn’t Always Mean Informed